1
Foundation of Addiction Management ECHO
2019
The materials are contributed by faculty and staffs of Centre for Addiction Medicine as well as NIMHANS Digital Academy.
Compiled by Ms Karishma and Mr Aurobind, NIMHANS Digital Academy
Please acknowledge Virtual Knowledge Network, Centre for Addiction Medicine NIMHANS
(web link) Feed back: [email protected]
2
Table of Content
1. Addiction: an Overview
Prof. Pratima Murthy ……………………………………………………………………………………..……….. 06
2. Types of emerging addictive drugs/non-drug
Dr. Dipthadhi ………………………………………………………………………………………….….…..…….... 44
3. Assessments specific to Addiction Rating scales: AUDIT/ASSIST/ASRS
Dr Narasimha ……………………………………………………………………………………….….…...……….. 97
4. Understanding Addiction: Neurobiology
Prof. Vivek Benegal ………………………………………………………………………….….……..…….……..113
5. Is addiction heritable?
Dr. Bharath Holla ………………………………………………………………………….…….….….….…….…. 168
6. Urine Screening for clinical practice
Mrs. Shravanthi Daphinet …………………………………………………………….…….……..….………... 205
7. Vulnerability : Why some get addicted and majority NOT!
Dr Arun Kandasamy ……………………………………………………………………….……….….………….. 258
8. Role of Psychosocial factors in substance abuse
Ms Karishma Khan ……………………………………………………………………..………….…….………… 294
3
Table of Content
9. Alcohol and its Physiological effects
Dr. Sumit Kumar Durugoji ……………………………………………………………………………………………. 325
10. Use -Abuse -Addiction Screening, Brief Intervention & Referral to Treatment (SBIRT)
Dr Prabhat ……………………………………………………………………………………………………….………… 352
11. Managing Alcohol Withdrawal: Simple
Dr Deepak G …………………………………………………………………………………………………..…………… 389
12. Managing Alcohol Withdrawal: Complicated
Dr Jaikrishnan ……………………………………………………………………………………………………………. 421
13. Alcohol Liver disease
Dr. Sagar ………………………………………………………………………………………………………..…………. 442
14. Prescribing Anticraving agents I (approved):Disulfiram, Acamprosate and Naltrexone
Dr Pawan ………………………………………………………………………………………………………………..… 473
15. Prescribing Anticraving agent II (off-label):
Baclofen, Topiramate, Gabapentin and Varenicline
Dr Shabina Sheth …………………………………………………………………………………………….……….… 517
4
Table of Content
16. Psychosocial intervention in Alcohol use Disorder - Increasing Motivation 1
Ms Sandeepa ………………………………………………………………………………………………………….. 549
17. Psychosocial intervention in Alcohol use Disorder - Increasing Motivation II
Ms Shikha ………………………………………………………………………………………………………………. 573
18. Psychosocial intervention in Alcohol use Disorder - Relapse Prevention
Dr E. Sinu ……………………………………………………………………………………………………………….. 611
19. Psychosocial intervention in Alcohol use Disorder - Cognitive Behavior Therapy
Dr Seema …………………………………………………………………………………………………………….…. 640
20. Psychosocial intervention in Alcohol use Disorder - 12 step facilitation
Ms Karishma ……………………………………………………………………………………………….…….…… 666
.
21. Alternate and Complementary Therapy for Substance use disorders
(Evidence for Yoga and Mindfulness)
Dr Geetha L …………………………………………………………………………………………….………….…. 702
22. Effective Family therapy
Ms Shilpa ………………………………………………………………………………………………………….…… 735
5
An introduction to addiction
Pratima Murthy
Professor of Psychiatry
Centre for Addiction Medicine
NIMHANS, Bangalore
6
Tobacco, other drugs and
addictive behaviours
7
What are ‘substances’?
• LEGAL • ILLEGAL
– Tobacco – Cannabis (ganja, charas,
– Alcohol marijuana
– Prescription medicines
– Opioids (heroin or brown
• Sleeping tablets sugar, opium, synthetic
(benzodiazepines) opioids
• Cough syrup (containing – Stimulants (amphetamines,
codeine) cocaine)
• Prescription pain killers – Hallucinogens (LSD,
(containing opioids) Ecstacy)
• Antihistamines – Inhalants (whitener, petrol)
• Other psychotropic
medicines
1. They are used because of their mind altering properties 8
2. The patterns of use of many substances change over time
3. The majority of public health problems occur from legal
substances!!!
Substance Use Patterns
Patterns of Use Impact (on individual, family, work
and society)
• Experimental Use
• Recreational Use • Health
• Intoxication • Intoxication
• High risk or Hazardous • Crime
• Violence
use • Injury
• Harmful Use • Emotional problems to
• Addiction or
family members
Dependence • Problems at workplace
9
Substance misuse as a growing
problem
• Alcohol and drug use contribute substantially
to the global burden of disease, not only
through substance use disorders but also from
other disease consequences resulting from
use.
Estimated cases Age-standardised prevalence/100000 (2016)
Alcohol 100·4 million 1320.8
dependence 289.7
353.0
Cannabis 22.1 million
dependence
Opioid dependence 26.8 million
Degenhardt et al 201810
World Drug Report 2018
• 275 million people worldwide, which is roughly 5.6 per
cent of the global population aged 15-64 years, used
drugs at least once during 2016.
• Some 31 million of people who use drugs suffer from
drug use disorders
• Roughly 450,000 people died as a result of drug use in
2015, according to WHO. Of those deaths, 167,750
were directly associated with drug use disorders
(mainly overdoses).
• The rest were indirectly attributable to drug use and
included deaths related to HIV and hepatitis C
acquired through unsafe injecting practices.
11
Alcohol use prevalence in India
NHSDA 2004 12
Substance use disorder (NMHS 2015-16)
13
Higher levels of use
• Poverty
• Illiteracy
• Certain employment sectors
• Unemployed Youth
• Vulnerable sections of society
• Cohort effect
14
IDU estimates-NACO
• A mapping exercise carried out by NACO (2010) estimates
the total median number of IDUs at 177 000. Whereas
heroin injecting is prevalent in certain parts of the country
such as Manipur, pharmaceutical injecting is widespread
across the country.
• Pharmaceutical drugs are often used in combination by
IDUs and the popular ‘cocktails’ contain synthetic opioids
(e.g., buprenorphine injection), benzodiazepines (e.g.,
diazepam), and antihistamines such as promethazine or
pheniramine maleate.
• In the North-East, injecting of dextropropoxyphene (spasmo
proxyvon/proxyvon) is not uncommon.
• This has also spread to other parts of the country
15
Growing population of women
affected by drugs
In India, while there were only case reports of women who injected drugs in the
1980’s, in the last two decades, rapid assessment and purposive surveys indicate a
growing population of women who use drugs, as well as inject drugs throughout the
country. Women partners of men who inject drugs receive inadequate attention.
16
Emerging patterns among women
using drugs
17
US – In 2010, 6.8% Germany : 15-25 per cent of the Russian Federation – 10 times
females and 11.2% males “hard-core” substance users women increase in addiction among women
reported current illicit EU- rates of pharmaceutical abuse Afghanistan – increasing use of
drug use higher among women opiates and pharmaceuticals among
Hardly any gender differences refugee women
between teenage girls and boys in Iran -6% of drug users are women
rates of cannabis use
UK-5.4% of women reported using China-increasing number of
drugs in 2009/10; 21% girls reported women using substances; report
ever using drugs in 2009 of sex for drugs among
women-opiates most common
Kenya- one heroin using Research reports indicate that women
women for every 20 are currently using drugs in Bangladesh,
males; many work in the China, India, Indonesia, Japan, Malaysia,
Brazil: a higher proportion of females sex industry Nepal, Pakistan, Philippines, Sri Lanka,
than males initiated cocaine use in a
study in Sao Paulo South Africa – growing Taiwan, Thailand and Vietnam, while
Chile- alcohol use increased among
adolescent females compared to males methamphetamine use there are likely many undocumented
Higher rates of cocaine dependence
reported among females than males among women, including cases in other Asian nations
(though lifetime use and recent use
more among males) pregnant women
Australia: 37.4 per cent of male and 37.9 per cent of
female 14-19 year olds report ever using an illicit
substance. Female rates of ever injecting a
substance in this group exceed those of males (1.7
per cent versus 1.0 per cent).
18
Foetal Alcohol Syndrome
Raghavendra, Murthy et al
19
Common factors associated with
adolescent drug use
Availability,
Accessibility,
acceptability of drug
use lack of
alternatives
Peer influence,
influence of
popular media,
poor life skills
Temperament
and coping, life
events
Family history
(genetic
vulnerability,
modelling)
Family support
(composition, drug
use, monitoring)
20
21
Mental health morbidity and lifetime
substance use in prison
Badamath, Murthy et al 222010
Substance use in the Elderly a
growing problem 23
Consequences
Mortality Injuries
Total deaths attributable RTA- one in four
to alcohol unclear
Traumatic brain
10% of all deaths & 15 to injuries-one in three
20% of premature
mortality attributable to Emergency room- nearly 2
alcohol (Gururaj 2006) out of 3
(Gururaj et al 2004,
Benegal, Gururaj,
Murthy et al 2001)
24
Consequences-studies from home and
farther afield
• Neuropsychiatric • Cancer
problems, particularly • Cirrhosis
seizures • Stroke
• Coronary artery disease
• Alcohol and high risk • Hypertension
behaviour • Dyslipidaemia
• Community related harm
• Suicide • Domestic violence
• Socio-economic costs
• Socio-economic losses
• Gender
• Foetal alcohol syndrome
• Psychiatric co-morbidity
Benegal et al 2001, 2004, Bonu et al 2004, Chandra et al 2003, Gururaj et al 2004, 2006,
Murthy et al 2008, 2010, Naik et al 2011, Nagaraja et al 2005, Narawane et al 1998,
Shanmugaiah et al 2001, Satyanarayana et al 2010, Vaswani et al 1997, Vohra et al 20032.5
Health
• All substances - Injuries, nutritional problems,
HIV and STI risk behaviours, CVD, cancers,
neuropsychiatric complications, liver disease,
mortality, suicides
• Alcohol – known to cause more than 60
disease conditions
• Tobacco – contains 4000 chemicals including
43 cancer causing chemicals
• Injecting drug use – infection, STIs, cardiac
complications
26
Public health aspects
• Multiple public health problems
have a direct or indirect
association with alcohol and
other substances
• Health, economic and social
burden from the use of
substances
• Low rates of detection
• More than a 10 year delay in help
seeking for alcohol related
problems
• Policies and stigmatising
attitudes deter help-seeking
• Inadequate treatment services
27
Addiction- a brain disease
Addiction is not simply a failure of will or
lack of strength of character, but occurs due
to changes in the brain
It is a chronic relapsing condition, similar to
hypertension and diabetes
Affected persons need to be educated,
supported, treated and followed-up
28
Principles of prevention and
intervention
The ILO Traffic Light • Red zone (Addiction)
–intensive care and
support
• Amber zone- educate
and motivate and focus
on self-change
• Green zone-keep the
greens green. Healthy
lifestyles
29
1. Principles of prevention
Enhance protective Should address all Messages should be
factors and reduce forms of drug abuse tailored to audience
characteristics (age,
risk factors (licit/illicit,
prescription drugs, background,
any substance with location)
abuse potential)
In order to be effective, preventive efforts should be long-term and
repeated (NIDA 2003)
30
Addressing risks and protective factors
NIDA 2003 31
INTERRELATIONSHIP BETWEEN TOBACCO & OTHER RISK FACTORS and NCDs
DIABETES CANCER COMMON
MENTAL
HEALTH
DISORDER
CARDIOVASCULAR STROKE
DISEASES
TOBACCO
STRESS UNHEALTHY
ALCOHOL DIET
PHYSICAL 32
INACTIVITY
x
Pratima Murthy
Professor of Psychiatry
Centre for Addiction Medicine
NIMHANS
Bangalore 33
Slide courtesy: Dr Alok Sarin
“Caregivers express-we are losing our
love ones to Technology- “Need help”
• Kids 4-5 years handling mobile phones
• Kids facebooking by age 11
• One in twenty kids between 18-25 addicted to
social media
• 8% reported problematic internet use (Manoj
Kumar et al 2011, 2012).
34
Buzzfield.com 35
Five ‘schools’ of thought
1) Addictive disorder
2) Impulsive - Compulsive spectrum disorder
3) Reshaping of “established” psychiatric disorders and
phenomena (anxiety, depression, OCD, ADHD, ASPD)
4) Combination of all above (continuum vs categorical)
5) It is not a ‘disorder’ at all but rather a sociocultural
phenomenon that should not be ‘medicalised’ at all
36
Broad approaches
• Overdose/Intoxication/Excessive use
• Withdrawal
• Relapse Prevention
• Harm minimization
• Approach as a chronic relapsing disorder
• Pharmacotherapeutic approaches
• Psychosocial approaches
37
38
Interventions to address the huge
treatment gap
• Brief interventions
• Outpatient and inpatient treatment
• Emergency room management
• Integrated medical and psycho-social
management
• Follow-up and aftercare
• Mobilising community support
• Community resource networking (health, welfare,
education, labour, voluntary sector…)
• Preventive policies and comprehensive programs
39
All values indicate %
40
Need for a shift to public health- led
policy
• Availability
• Politics
• Consumption
• Consequences
• Responses
• Need for a coherent
policy
NIMHANS- Epidemiology and 41
Centre for Addiction Medicine
Policies, laws and regulations
• Address issues of supply and demand
• Be responsive to ground realities
Regular monitoring of on the ground situation
(prevalence of the problem, target groups affected,
causes, consequences, responses, response gap analysis)
• Deterrence of supply violations, restrict use, provide
treatment, respect human rights of users
• Involve other stakeholders – media, local leaders,
religious leaders, key opinion makers,
parliamentarians
42
Conclusion
• Substance use a growing global and national
concern
• Divisions between different drugs is artificial and
many use licit and illicit drugs both of which
produce serious problems for individuals, families
and the community
• Programs must take into concern holistically
addressing antecedent factors and consequences of
substance misuse and addiction
• Resources and strategies for both prevention and
intervention, as well as monitoring must be
generated
43
Types of emerging
Addictive
drugs/non-drug
Dr Diptadhi Mukherjee
DM Addiction Psychiatry Senior resident
CAM, NIMHANS
44
Types of Drugs
Legal provision Mechanism of action
• Licit
✓ Alcohol
✓ Tobacco
• Illicit
45
Yet another classification….
• “Classic”/ “Traditional” • Newer psychoactive
drugs substances (NPS)/
“Designer” drugs/
• Like heroin, cocaine, Emerging Drugs
alcohol
46
• What do we mean by emerging addictive drugs?
➢ Drugs (with little or no history of medical) discovered to
be used recently with addictive potential used for
recreational purpose
➢ Drugs used for medical purposes for many years back,
but being used for recreational purposes in recent time
➢ Drugs used in specific region of world as traditional use
but has been found to be used by many other parts of
the world
➢ Drugs of addictive potential yet to be included in the
under international control (or included very recently)
• Most of the definitions include epidemiological
characteristics.
47
NPS
• Concept of Newer Psychoactive Substances (NPS)
• UNODC started global monitoring of NPS in 2009
• The substances reported by the largest number of
countries and territories include ketamine, khat,
JWH-018, methylone, 4-methylmethcathinone,
25I-NBOMe, 5F-APINACA which were each
reported by at least 47 countries.
• With exception of ketamine and khat, all of those
substances were placed under international control
between 2015 and 2017.
48
Cannabis
(Bhang, Charas, Ganja,
Hashish)
49
Cannabis products
• Bhang (leaves) Oral
Smoked
• Ganja (dried
flowering stem of the Smoked
plant)
Smoked
• Charas / Hashish
(extracted from the
resin covering the
plant)
• Hashish Oil
(extracting THC using
chemical methods)
-50-